Lanxess subsidiary to spend €50m on upgrades

14 February 2008 11:09  [Source: ICIS news]

LONDON (ICIS news)--Saltigo will spend around €50m ($72m) by the end of 2009 in improving its plants in Germany's North Rhine-Westphalia region, parent company Lanxess said on Thursday as its subsidiary officially opened a new €10m multi-purpose unit.

 

Pharmaceutical ingredients and intermediates would be produced at the facility at Leverkeusen Chempark, it added.

 

“We will continue our process of investment to further enhance Saltigo’s performance and competitiveness, and continuously adapt our facilities to the market requirements,” said Saltigo’s managing director Wofgang Schmitz.

 

The new plant would produce more than 200 tonnes of active pharmaceutical ingredients and registered intermediates a year, the company said.

 

Saltigo is involved in the custom synthesis of substances for the agrochemical and pharmaceutical industries and in specialty chemicals.

 

($1 = €0.69)

By: Lucy Craymer
+44 20 8652 3214

< previous article(VIDEO - ICIS news Asia Lunchtime Bulletin 3 November 2009)

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly